SANTA CRUZ, Calif., June 5, 2018 /PRNewswire/ -- Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve ...
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results